Lakshmi Kotra
Director/Board Member bei FSD PHARMA INC.
Vermögen: 1 Mio $ am 31.03.2024
Profil
Lakshmi P.
Kotra is the founder of WinSanTor, Inc. (founded in 2011) and Lucid Psycheceuticals, Inc. (founded in 2020).
Currently, Dr. Kotra holds the position of Chief Executive Officer & Director at Lucid Psycheceuticals, Inc. Dr. Kotra is also currently a Director at FSD Pharma, Inc. (since 2022) and Celly Nutrition Corp.
Dr. Kotra obtained a doctorate degree from the University of Georgia.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
FSD PHARMA INC. CLASS B
3,56% | 28.03.2024 | 1 422 197 ( 3,56% ) | 1 Mio $ | 31.03.2024 |
Celly Nutrition Corp.
inf% | 29.11.2023 | 1 422 197 ( inf% ) | - $ | Heute |
Aktive Positionen von Lakshmi Kotra
| Unternehmen | Position | Beginn |
|---|---|---|
| FSD PHARMA INC. | Director/Board Member | 25.11.2022 |
Lucid Psycheceuticals, Inc.
 Lucid Psycheceuticals, Inc. Medical/Nursing ServicesHealth Services Part of FSD Pharma, Inc., Lucid Psycheceuticals, Inc. is a biotech company based in Toronto, CA. Lucid Psycheceuticals was acquired by FSD Pharma, Inc. on September 21, 2021 for $6.64 million. Lucid Psycheceuticals is exploring novel therapies to address total brain health, including mental health disorders and neurodegenerative disorders. The Canadian company has two active pipelines under development and is inspired by the mechanisms of action of psychedelics to prevent and possibly reverse neurodegeneration. The private company was founded by Lakshmi P. Kotra and Joseph L. Romano, with Lakshmi P. Kotra serving as the CEO since incorporation. | Founder | 01.02.2020 |
| Celly Nutrition Corp. | Director/Board Member | - |
Ehemalige bekannte Positionen von Lakshmi Kotra
| Unternehmen | Position | Ende |
|---|---|---|
WinSanTor, Inc.
 WinSanTor, Inc. Pharmaceuticals: MajorHealth Technology WinSanTor, Inc. operates as a clinical-stage biotechnology company. The firm focuses on the discovery and development of treatments for peripheral neuropathies, including diabetic peripheral neuropathy, chemo-induced peripheral neuropathy, HIV-induced and others. The company was founded by Stanley Kim, Nigel Calcutt, Paul Fernyhough and Lakshmi P. Kotra in 2011 and is headquartered in San Diego, CA. | Founder | - |
Ausbildung von Lakshmi Kotra
| University of Georgia | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FSD PHARMA INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
WinSanTor, Inc.
WinSanTor, Inc. Pharmaceuticals: MajorHealth Technology WinSanTor, Inc. operates as a clinical-stage biotechnology company. The firm focuses on the discovery and development of treatments for peripheral neuropathies, including diabetic peripheral neuropathy, chemo-induced peripheral neuropathy, HIV-induced and others. The company was founded by Stanley Kim, Nigel Calcutt, Paul Fernyhough and Lakshmi P. Kotra in 2011 and is headquartered in San Diego, CA. | Health Technology |
Lucid Psycheceuticals, Inc.
Lucid Psycheceuticals, Inc. Medical/Nursing ServicesHealth Services Part of FSD Pharma, Inc., Lucid Psycheceuticals, Inc. is a biotech company based in Toronto, CA. Lucid Psycheceuticals was acquired by FSD Pharma, Inc. on September 21, 2021 for $6.64 million. Lucid Psycheceuticals is exploring novel therapies to address total brain health, including mental health disorders and neurodegenerative disorders. The Canadian company has two active pipelines under development and is inspired by the mechanisms of action of psychedelics to prevent and possibly reverse neurodegeneration. The private company was founded by Lakshmi P. Kotra and Joseph L. Romano, with Lakshmi P. Kotra serving as the CEO since incorporation. | Health Services |
| Celly Nutrition Corp. |
